Andermatt Biocontrol Suisse, the Swiss-based Andermatt Group subsidiary, has partnered with CondioTec LLC (USA) to introduce the Aprehend biopesticide for the control and prevention of bed bugs in Europe.
Aprehend is a fungal biopesticide based on an oil formulation of Beauveria bassiana, a natural fungal disease of insects.
Aprehend is registered in the US and Canada and has rapidly become the go-to product for pest professionals to control and prevent bed bug infestations in North America.
Andermatt Biocontrol Suisse will formulate Aprehend with a highly effective B. bassiana strain of the South African sister company Andermatt PHP and will undertake biocide registration for the EU.
Andermatt Biocontrol Suisse chief executive Martin Günter said: “Bringing an established microbial solution for bed bugs in North America to the European market is crucial for pest professionals tackling the increasing bed bug problem in Europe.
“We are pleased about this partnership with CondioTec and this opportunity to extend our portfolio of biocide solutions. The Andermatt network is looking forward to developing its reach into this market.”
Don McCandless, chief executive of ConidioTec, added: “This is a tremendous opportunity to provide our proven bed bug treatment, Aprehend, to the European market alongside an established biological products leader such as Andermatt Biocontrol Suisse.
“We think this is a winning combination of expertise for a successful launch.”
